Data / Form D filings / Sunshine Biopharma, Inc
Sunshine Biopharma, Inc: Form D filings
Sunshine Biopharma, Inc, a pharmaceuticals company in Pointe-Claire, Quebec, Canada, filed 4 Form D notices with the SEC between 2012 and 2023. The latest, on May 17, 2023, reports $5 million sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6500 TRANS-CANADA HIGHWAY, 4TH FLOOR, Pointe-Claire, Quebec, Canada, H9R 0
- Phone
- (514) 426-6161
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Colorado
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1402328
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 17, 2023 | New notice | $4,996,497 | $4,996,497 | 1 | May 12, 2023 | sec.gov | |
| Apr 29, 2022 | New notice | $19,497,618 | $19,497,618 | 9 | Apr 25, 2022 | sec.gov | |
| Mar 18, 2022 | New notice | $7,998,699 | $7,998,699 | 9 | Mar 10, 2022 | sec.gov | |
| Aug 24, 2012 | New notice | $5,000,000 | $459,313 | $4,540,687 | 7 | Jul 13, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rabi N. Kiderach | Director | |
| Steve N. Slilaty | Executive Officer, Director | |
| Abderrazzak N. Merzouki | Executive Officer, Director | |
| David N. Natan | Director | |
| Camille N. Sebaaly | Executive Officer | |
| Andrew N. Keller | Director |
Every Form D from the week of May 15, 2023 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sunshine Biopharma, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.